Bioavailability of oral fluconazole in critically ill abdominal trauma patients with and without abdominal wall closure: A randomized crossover clinical trial

Journal of Trauma - Injury, Infection and Critical Care

Volumn 63, Issue 1, 2007, Pages 159-163

  Barquist, Erik S ^a   Gomez Fein, Eleanor ^b   Block, Ernest F J ^a   Collin, Gary ^a   Alzamel, Heythem ^a   Martinez, Octavio ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

Bioavailability; Critical illness; Fluconazole; Laparostomy; Open abdomen; Pharmacokinetics; Surgery complications

Indexed keywords

FLUCONAZOLE;

ABDOMINAL INJURY; ABDOMINAL WALL CLOSURE; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CANDIDA KRUSEI; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG URINE LEVEL; FECES CULTURE; FEMALE; FUNGAL COLONIZATION; FUNGAL DETECTION; HUMAN; INJURY SCALE; LAPAROTOMY; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT DURATION;

ABDOMINAL INJURIES; ABDOMINAL WALL; ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CRITICAL ILLNESS; CROSS-OVER STUDIES; ENTERAL NUTRITION; FECES; FLUCONAZOLE; HUMANS; INFUSIONS, PARENTERAL; INTESTINAL ABSORPTION; MIDDLE AGED; PARENTERAL NUTRITION; WOUNDS, GUNSHOT;

EID: 34447319700     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000232011.59630.93     Document Type: Article

References (33)

1. Morris JA, Jr, Eddy VA, Blinman TA, Rutherford EJ, Sharp KW. The staged celiotomy for trauma: issues in unpacking and reconstruction. Ann Surg. 1992;215:576-586.
2. Burch JM, Ortiz VB, Richardson RJ. Abbreviated laparostomy and planned reoperation for critically injured patients. Ann Surg. 1992;215:476-489.
3. Rotondo MF, Schwab CW, McGonigal MD. "Damage control" an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35:375-382.
4. Schein M. Surgical management of intra-abdominal infection: is there any evidence? Langenbeck's Arch Surg. 2002;387:1-7.
5. Lamme B, Boermeester A, Reitsma JB, Mahler CW, Obertop H, Gouma DJ. Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg. 2002;89:1516-1524.
6. Bhushan C, Mital VK, Elhence IP. Continuous postoperative peritoneal lavage in diffuse peritontitis using balanced saline antibiotic solution. Int Surg. 1975;60:526-528.
7. Brammer KW, Farrow PR, Faulkner JK. Pharmakokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990;12(Suppl 3):S318-S326.
8. Mycek MJ, Harvey RA, Champe PC. Lippincott's Illustrated Reviews, Pharmacology, 2nd Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
9. Leiboff AR, Soroff HS. The treatment of generalized peritonitis by closed postoperative peritoneal lavage. Ann Surg. 1987;122:1005-1010.
10. Kinney EV, Polk HC. Open treatment of peritonitis: an argument against. Adv Surg. 1987;21:19-28.
11. Nathens AB, Rotstein OD. Therapeutic options in peritonitis. Surg Inf. 1994;74:677-692.
12. Reemst PH, van Goor H, Goris RJ. SIRS, MODS and tertiary peritonitis. Eur J Surg Suppl. 1996;576:47-49.
13. Miller PR, Thompson JT, Faler BJ, Meredith W, Chang MC. Late fascial closure in lieu of ventral hernia: the next step in open abdomen management. J Trauma. 2002;53:843-849.
14. Sleeman D, Sosa JL, Gonzalez A, et al. Reclosure of the open abdomen. J Am Coll Surg. 1995;180:200-204.
15. Losanoff JE, Kjossev KT. Mesh-foil laparostomy. J Am Coll Surg. 1997;185:89-92.
16. Losanoff JE, Richman BW, Jones JW. Combined ventral and retroperitoneal laparostomy in ballistic trauma to the colon and retroperitoneum. Am J Surg. 2002;184:170-173.
17. Barker DE, Kaufman HJ, Smith LA, Ciraulo DL, Richart CL, Burns RP. Vacuum pack technique of temporary abdominal closure; a 7 year experience with 112 patients. J Trauma. 2000;48:210-207.
18. Tremblay LN, Feliciano DV, Schmidt J, et al. Skin only or silo closure in the critically ill patient with an open abdomen. Am J Surg. 2001;182:670-675.
19. Paran H, Mayo A, Afanasiev A, et al. Staged primary closure of the abdominal wall in patients with abdominal compartment syndrome. J Trauma. 2001;51:1204-1206.
20. Garner GB, Ware DN, Cocanour CS, et al. Vacuum-assisted wound closure provides early fascial reapproximation in trauma patients with open abdomens. Am J Surg. 2001;182:630-638.
21. Girard S, Sideman M, Spain DA. A novel approach to the problem of intestinal fistulization arising in patients managed with open peritoneal cavities. Am J Surg. 2002;184:166-167.
22. Schachtrupp A, Hoer J, Tons C, Klinge U, Reckord U, Schumpelick V. Intra-abdominal pressure: a reliable criterion for laparostomy closure? Hernia. 2002;6:102-107.
23. Bodenham A, Shelly MP, Park GR. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet. 1988;14:347-373.
24. Mann HJ, Fuhs DW, Cerra FB. Pharmacokinetics and pharmacodynamics in critically ill patients. World J Surg. 1987;11:210-217.
25. Boucher BA, Rodman JH, Fabian TC, et al. Disposition of phenytoin in critically ill trauma patients. Clin Pharm. 1987;6:881-887.
26. Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. J Trauma. 2000;49:869-72.
27. Mann HJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm. 1987;6:148-153.
28. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542-548.
29. Wallace JE, Harris SC, Gallegos J. Assay of fluconazole by high-performance liquid chromatography with a mixed phase column. Antimicrob Agents Chemother. 1992;36:603-606.
30. Rosemurgy AS, Markowsky S, Goode SE, Plastino K, Kearney RE. Bioavailability of fluconazole in surgical intensive care unit patients. J Trauma. 1995;39:445-447.
31. Nicolau DP, Crowe H, Nightingale CH, Quintiliani R. Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients. J Antimicro Chemo. 1995;36:395-401.
32. Buijk SLCE, Gyssens IC, Mouton JW, Verbrugh HA, Touw DJ, Bruining HA. Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function. Intensive Care Med. 2001;27:115-121.
33. Rajagopalan P, Pelz RK, Lipsett PA, Swoboda SM, Rinaldi MG, Hendrix CW. Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit. Pharmacotherapy. 2003;23:592-602.